Anticancer treatment strategies increasingly seek to raise reactive oxygen species (ROS) levels, cause macromolecular damage, and kill cancer cells. Electromagnetic fields can elevate intracellular reactive oxygen species ...
Known as two of the most lethal cancers, ovarian and pancreatic cancer are often called silent killers since they rarely have early symptoms. As a result, they frequently go undetected until they're too late to effectively ...
Jul 22, 2019
0
6
Scientists have recently concluded a preclinical study that highlights the potential of SIWA318H, an advanced glycation end product (AGE)-targeting antibody, in the fight against pancreatic cancer. The results are published ...
Oct 27, 2023
0
44
Obesity has been linked to increased risk for over a dozen different types of cancer, as well as worse prognosis and survival. Over the years, scientists have identified obesity-related processes that drive tumor growth, ...
Dec 9, 2020
0
101
If cancer is a series of puzzles, a new study pieces together how several of those puzzles connect to form a bigger picture.
Sep 2, 2020
0
63
New Cleveland Clinic research has found that drugs originally designed to help treat Alzheimer's disease may hold promise for glioblastoma, the most common and lethal type of primary brain tumor. The findings were published ...
Nov 23, 2021
0
60
A research team led by investigators at Massachusetts General Hospital (MGH) and the Massachusetts Institute of Technology (MIT) has found that combining a specialized version of an antihypertension drug with immune checkpoint ...
Apr 29, 2019
0
112
A new multidrug treatment for patients with stage IV melanoma has proven effective after a three-year clinical trial at the University of Colorado Cancer Center.
Dec 16, 2022
0
29
Patients at Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare were the first in the nation to participate in a clinical trial to determine the safety, tolerability and effectiveness for usage of a new ...
Oct 4, 2011
0
0
Ludwig Cancer Research scientists have developed a method to significantly improve the preclinical evaluation of chimeric antigen-receptor (CAR) T cell therapies, in which the immune system's T cells are extracted from a ...
Nov 6, 2020
0
14
